Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-10 Sale |
2025-02-12 9:00 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
139,064 | $1.76 | $244,753 | 1,160,634 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 9:00 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
12,048 | $1.76 | $21,204 | 279,655 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 9:00 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael SVP, CMO, Head-Res&Drug |
41,269 | $1.76 | $72,633 | 554,007 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 9:00 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
38,938 | $1.76 | $68,531 | 408,132 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 9:00 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Martini Gregory S. Chief Financial Officer |
12,052 | $1.76 | $21,212 | 183,810 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
5,360 | $4.08 | $21,869 | 284,685 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, COO and CFO |
11,001 | $4.08 | $44,884 | 309,572 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 5:10 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
9,910 | $4.27 | $42,316 | 284,661 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 5:08 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
3,107 | $4.27 | $13,267 | 158,370 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-12 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | McHugh Julie Director |
22,766 | $6.29 | $143,198 | 139,528 (Direct) |
View |
| 2024-06-06 Sale |
2024-06-10 4:58 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director |
80,000 | $6.4712 | $517,694 | 48,633 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
67,618 | $6.45 | $436,136 | 1,150,330 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
22,725 | $6.45 | $146,576 | 288,031 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug |
16,128 | $6.45 | $104,026 | 413,719 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
17,404 | $6.45 | $112,256 | 294,571 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-02 Option Award |
2025-04-04 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
10,416 | $0 | 16,556,769 (Direct) |
View |
Ownership |
2025-03-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Gaskins Tammi L Chief Commercial Officer |
0 | $0 | 245,159 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 9:00 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael SVP, CMO, Head-Res&Drug |
133,333 | $0 | 554,007 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 9:00 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
122,222 | $0 | 408,132 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 5:30 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer |
133,333 | $0 | 291,703 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 5:30 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Martini Gregory S. Chief Financial Officer |
111,111 | $0 | 195,862 (Direct) |
View |
Ownership |
2025-01-29 5:29 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Martini Gregory S. Chief Financial Officer |
0 | $0 | 89,645 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 5:04 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael SVP, CMO, Head-Res&Drug |
48,224 | $0 | 461,943 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 4:38 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
40,187 | $0 | 324,848 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 4:35 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer |
147,354 | $0 | 1,299,698 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
4,249 | $0 | 16,546,353 (Direct) |
View |
| 2024-09-16 Option Award |
2024-09-18 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
3,282 | $0 | 16,542,104 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shepard Jay Director |
24,311 | $0 | 126,555 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Dreyfus Andrew Director |
24,311 | $0 | 188,230 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Duane Jon R Director |
24,311 | $0 | 145,339 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director |
24,311 | $0 | 72,944 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | McHugh Julie Director |
24,311 | $0 | 163,839 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Kessler Marla L Director |
24,311 | $0 | 120,883 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
24,311 | $0 | 16,538,822 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Currie Mark G Director |
24,311 | $0 | 568,419 (Direct) |
View |
| 2024-06-15 Option Award |
2024-06-18 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
2,572 | $0 | 16,514,511 (Direct) |
View |
| 2024-05-16 Tax Withholding |
2024-05-20 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
18,280 | $6.64 | 320,573 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner |
1,662 | $0 | 16,511,939 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer |
32,752 | $0 | 311,975 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
37,120 | $0 | 338,853 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug |
34,936 | $0 | 429,847 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer |
37,120 | $0 | 310,756 (Direct) |
View |